CoChat

Germline Lysine-Specific Demethylase 1 ( LSD1/KDM1A ) Mutations Confer Susceptibility to Multiple Myeloma

Open access
Wei, Xiaomu, Calvo-Vidal, M. Nieves, Chen, Siwei, Wu, Gang, Revuelta, Maria V., Sun, Jian, Zhang, Jinghui, Walsh, Michael F., Nichols, Kim E., Joseph, Vijai, Snyder, Carrie, Vachon, Celine M., McKay, James D., Wang, Shu-Ping, Jayabalan, David S., Jacobs, Lauren M., Becirovic, Dina, Waller, Rosalie G., Artomov, Mykyta, Viale, Agnes, Patel, Jayeshkumar, Phillip, Jude, Chen-Kiang, Selina, Curtin, Karen, Salama, Mohamed, Atanackovic, Djordje, Niesvizky, Ruben, Landgren, Ola, Slager, Susan L., Godley, Lucy A., Churpek, Jane, Garber, Judy E., Anderson, Kenneth C., Daly, Mark J., Roeder, Robert G., Dumontet, Charles, Lynch, Henry T., Mullighan, Charles G., Camp, Nicola J., Offit, Kenneth, Klein, Robert J., Yu, Haiyuan, Cerchietti, Leandro, Lipkin, Steven M. · 2018 · Cancer Research
Cited by 85

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Given the frequent and largely incurable occurrence of multiple myeloma, identification of germline genetic mutations that predispose cells to multiple myeloma may provide insight into disease etiology and the developmental mechanisms of its cell of origin, the plasma cell (PC). Here, we identified familial and early-onset multiple myeloma kindreds with truncating mutations in lysine-specific demethylase 1 (LSD1/KDM1A), an epigenetic transcriptional repressor that primarily demethylates histone H3 on lysine 4 and regulates hematopoietic stem cell self-renewal. In addition, we found higher rates of germline truncating and predicted deleterious missense KDM1A mutations in patients with multiple myeloma unselected for family history compared with controls. Both monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma cells have significantly lower KDM1A transcript levels compared with normal PCs. Transcriptome analysis of multiple myeloma cells from KDM1A mutation carriers shows enrichment of pathways and MYC target genes previously associated with myeloma pathogenesis. In mice, antigen challenge followed by pharmacologic inhibition of KDM1A promoted PC expansion, enhanced secondary immune response, elicited appearance of serum paraprotein, and mediated upregulation of MYC transcriptional targets. These changes are consistent with the development of MGUS. Collectively, our findings show that KDM1A is the first autosomal-dominant multiple myeloma germline predisposition gene providing new insights into its mechanistic roles as a tumor suppressor during post-germinal center B-cell differentiation. Significance: KDM1A is the first germline autosomal dominant predisposition gene identified in multiple myeloma and provides new insights into multiple myeloma etiology and the mechanistic role of KDM1A as a tumor suppressor during post-germinal center B-cell differentiation. Cancer Res; 78(10); 2747–59. ©2018 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-17-1900

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 85

Metadata

Authors
Wei, X., Calvo-Vidal, M. N., Chen, S., Wu, G., Revuelta, M. V., Sun, J., Zhang, J., Walsh, M. F., Nichols, K. E., Joseph, V., Snyder, C., Vachon, C. M., McKay, J. D., Wang, S.-P., Jayabalan, D. S., Jacobs, L. M., Becirovic, D., Waller, R. G., Artomov, M., Viale, A., Patel, J., Phillip, J., Chen-Kiang, S., Curtin, K., Salama, M., Atanackovic, D., Niesvizky, R., Landgren, O., Slager, S. L., Godley, L. A., Churpek, J., Garber, J. E., Anderson, K. C., Daly, M. J., Roeder, R. G., Dumontet, C., Lynch, H. T., Mullighan, C. G., Camp, N. J., Offit, K., Klein, R. J., Yu, H., Cerchietti, L., & Lipkin, S. M.
Venue
Cancer Research
Published
2018-05-14
Volume
78
Issue
10
Pages
2747-2759
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2792051033
Cited by
85
References
17
FWCI
6.08
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Germline Lysine-Specific Demethylase 1 ( LSD1/KDM1A ) Mutations Confer Susceptibility to Multiple Myeloma. https://app.cochat.ai/papers/10.1158/0008-5472.can-17-1900
The paper
Wei, X., Calvo-Vidal, M. N., Chen, S., Wu, G., Revuelta, M. V., Sun, J., Zhang, J., Walsh, M. F., Nichols, K. E., Joseph, V., Snyder, C., Vachon, C. M., McKay, J. D., Wang, S.-P., Jayabalan, D. S., Jacobs, L. M., Becirovic, D., Waller, R. G., Artomov, M., . . . Lipkin, S. M. (2018). Germline Lysine-Specific Demethylase 1 ( LSD1/KDM1A ) Mutations Confer Susceptibility to Multiple Myeloma. Cancer Research. https://doi.org/10.1158/0008-5472.can-17-1900

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.